Globenewswire
Search documents
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
Globenewswire· 2026-02-23 13:00
CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously ...
TOP Ships Inc. Announces Agreement to Acquire Nine ECO MR Product Tanker Newbuildings with Time Charter Employment and Potential Gross Revenue Backlog of about $679 million
Globenewswire· 2026-02-23 13:00
ATHENS, Greece, Feb. 23, 2026 (GLOBE NEWSWIRE) -- TOP Ships Inc. (the “Company”), an international owner and operator of modern, fuel efficient "ECO" tanker vessels, announced today that it has entered into an agreement with an entity affiliated with the Company’s Chief Executive Officer, (“the Seller”), to acquire 100% of the issued and outstanding shares of nine Marshall Islands companies (the “SPVs”), counterparties to ship building contracts for nine very-high specification 47,499 dwt Medium Range (“MR” ...
Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
Globenewswire· 2026-02-23 13:00
WEST CHESTER, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive Officer of Verrica Pharmaceuticals, will present at the TD Cowen 46th Annual Healthcare Conference in Boston. TD Cowen 46th Annual Health Care Conference, March 2-4, 2026Event details:Date: Monday, March 2 ...
Lyell Immunopharma Announces Participation in March Investor Conferences
Globenewswire· 2026-02-23 13:00
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will present and participate in the following investor conferences: TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, in Boston, Massachusetts; presentation at 9:10am Eastern TimeLeerink An ...
Leading Heart Transplant Centers Convene in Houston for Picard Medical/ SynCardia’s Total Artificial Heart Surgical Training
Globenewswire· 2026-02-23 13:00
Invitation-only program at Houston Methodist, one of the top heart transplant centers in the U.S., highlights the growing need for SynCardia Total Artificial Heart technology. Training initiative at Houston Methodist is expected to enable expanded adoption of the SynCardia Total Artificial Heart through further education. TUCSON, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first ...
Uni-Fuels Expands Southeast Asia Footprint with New Regional Office in Thailand
Globenewswire· 2026-02-23 12:56
SINGAPORE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG) (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced the establishment of Uni-Fuels (Thailand) Co., Ltd. (“Uni-Fuels Thailand”), its newly incorporated regional entity, further strengthening the Company’s global supply and operations network. This follows the establishment of offices in Dubai, Shanghai, and Limassol in 2025 as part of Uni-Fuels’ ongoing glob ...
Virtuix to Host Third Quarter Fiscal Year 2026 Results Conference Call on Thursday, March 5, 2026 at 8:30 a.m. Eastern Time
Globenewswire· 2026-02-23 12:47
Core Insights - Virtuix Inc. will hold a conference call on March 5, 2026, to discuss its Q3 fiscal results for 2026 and provide updates on various initiatives [1][2] Company Updates - The company is joining the Made for Meta program, enhancing compatibility of its Omni One system with Meta Quest headsets and games [1] - Recent expansion of Omni One sales to Europe has been noted, indicating growth in international markets [1] - Integration of AI-driven Gaussian splatting technology into the Virtual Terrain Walk (VTW) system is a key development [1] Financial Information - The conference call will be hosted by CEO Jan Goetgeluk and CFO Thomas McGinnis, followed by a Q&A session [2] - A press release detailing the financial results will be issued prior to the call [1] Company Background - Virtuix Inc. is a leading manufacturer of full-body virtual reality systems, with a focus on consumer, enterprise, and defense markets [3] - The company's flagship product, the "Omni" omni-directional treadmill, allows users to walk and run in 360 degrees within virtual environments [3] - Virtuix is committed to innovation in XR and AI, aiming to deliver immersive experiences globally [3]
Verisk Analytics, Inc. Enters into $1.5 Billion Accelerated Share Repurchase Transaction
Globenewswire· 2026-02-23 12:30
JERSEY CITY, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verisk Analytics, Inc. (Nasdaq: VRSK) (“Verisk” or the “Company”), a leading strategic data analytics and technology partner to the global insurance industry, today announced that it has entered into accelerated share repurchase agreements (“ASR Agreements”) with each of HSBC Bank USA, National Association and Wells Fargo Bank, National Association (the “ASR Counterparties”) to repurchase an aggregate of $1.5 billion of the Company’s common stock. After g ...
ASP Isotopes Announces Quantum Leap Energy and Necsa Advance Strategic Collaboration Aimed at Production of HALEU Nuclear Fuel
Globenewswire· 2026-02-23 12:30
Agreement between QLE’s South African subsidiary and Necsa related to the siting, design, construction, commission and operation of an enrichment facility on the Necsa site in Pelindaba, with QLE’s objective to achieve market readiness for production of nuclear fuel The collaboration leverages QLE’s in-licensed and proprietary enrichment technology and Necsa’s globally-recognized production facilities DALLAS, Feb. 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that on ...
U.S. FDA Grants Reunion Neuroscience's Luvesilocin (RE104) Breakthrough Therapy Designation Status
Globenewswire· 2026-02-23 12:30
-- Breakthrough Therapy Designation Based on Positive RECONNECT Phase 2 Clinical Data ---- Aligned with U.S. Food and Drug Administration on Registrational Path for Luvesilocin in Postpartum Depression (PPD); On Track to Initiate Phase 3 Trial in 2026 -- MORRISTOWN, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Reunion Neuroscience, Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychede ...